NCT02964091View on ClinicalTrials.gov

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

August 28, 2020

Study Completion Date

August 28, 2020

Conditions

Chronic Hepatitis C

Interventions

DRUG

sofosbuvir/ledipasvir

Trial Locations (1)

00000

Rwanda Military Hospital, Kanombe

Sponsors

Lead Sponsor

Partners in Health

All Listed Sponsors

lead

Partners in Health

OTHER